BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 29442594)

  • 1. Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.
    Tao YX; Conn PM
    Physiol Rev; 2018 Apr; 98(2):697-725. PubMed ID: 29442594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoperone drugs: targeting misfolded proteins causing lysosomal storage-, ion channels-, and G protein-coupled receptors-associated conformational disorders.
    Hou ZS; Ulloa-Aguirre A; Tao YX
    Expert Rev Clin Pharmacol; 2018 Jun; 11(6):611-624. PubMed ID: 29851355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive Molecules.
    Ulloa-Aguirre A; Conn PM
    Curr Drug Targets; 2016; 17(13):1471-81. PubMed ID: 26953247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
    Sloan LA; Fillmore MC; Churcher I
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoperones: targeting therapeutics toward diseases caused by protein misfolding.
    Ulloa-Aguirre A; Zariñán T; Conn PM
    Rev Invest Clin; 2015; 67(1):15-9. PubMed ID: 25857579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteostasis: bad news and good news from the endoplasmic reticulum.
    Noack J; Brambilla Pisoni G; Molinari M
    Swiss Med Wkly; 2014; 144():w14001. PubMed ID: 25144910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease.
    Ulloa-Aguirre A; Janovick JA; Brothers SP; Conn PM
    Traffic; 2004 Nov; 5(11):821-37. PubMed ID: 15479448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening methods for identifying pharmacological chaperones.
    Shin MH; Lim HS
    Mol Biosyst; 2017 Mar; 13(4):638-647. PubMed ID: 28265599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Misfolding Diseases and Therapeutic Approaches.
    Yadav K; Yadav A; Vashistha P; Pandey VP; Dwivedi UN
    Curr Protein Pept Sci; 2019; 20(12):1226-1245. PubMed ID: 31187709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chaperoning Endoplasmic Reticulum-Associated Degradation (ERAD) and Protein Conformational Diseases.
    Needham PG; Guerriero CJ; Brodsky JL
    Cold Spring Harb Perspect Biol; 2019 Aug; 11(8):. PubMed ID: 30670468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
    Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
    Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of inner mitochondrial membrane protein misfolding.
    Coyne LP; Chen XJ
    Mitochondrion; 2019 Nov; 49():46-55. PubMed ID: 31195097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation.
    Kriegenburg F; Ellgaard L; Hartmann-Petersen R
    FEBS J; 2012 Feb; 279(4):532-42. PubMed ID: 22177318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.
    Muntau AC; Leandro J; Staudigl M; Mayer F; Gersting SW
    J Inherit Metab Dis; 2014 Jul; 37(4):505-23. PubMed ID: 24687294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical and/or biological therapeutic strategies to ameliorate protein misfolding diseases.
    Ong DS; Kelly JW
    Curr Opin Cell Biol; 2011 Apr; 23(2):231-8. PubMed ID: 21146391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.
    Marinko JT; Huang H; Penn WD; Capra JA; Schlebach JP; Sanders CR
    Chem Rev; 2019 May; 119(9):5537-5606. PubMed ID: 30608666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Misfolding Diseases.
    Hartl FU
    Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Small Heat Shock Proteins in Protein Misfolding Associated Motoneuron Diseases.
    Tedesco B; Ferrari V; Cozzi M; Chierichetti M; Casarotto E; Pramaggiore P; Mina F; Galbiati M; Rusmini P; Crippa V; Cristofani R; Poletti A
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the cytosolic HSP70 chaperone system in diseases caused by misfolding and aberrant trafficking of ion channels.
    Young JC
    Dis Model Mech; 2014 Mar; 7(3):319-29. PubMed ID: 24609033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.